Doctor profile · Federal record

Dr. Nikoletta Sidiropoulos, M.D.

Molecular Genetic Pathology (Medical Genetics) Physician · Burlington, VT

  • NPI 1356446017
  • 20 yrs on file
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
111 Colchester Ave
Burlington, VT 054011473
(802) 356-7323

Credentials & registration

NPPES · NUCC
NPI registered
September 2006 — 20 yrs on file
Profile last updated
August 14, 2013
Specialty taxonomy
207SM0001X — NUCC code
State license (1)
Vermont #042.0011781

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1356446017. Last verified May 11, 2026.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$11,014
Transactions
7
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Illumina, INC. 5 $6,236.78
AstraZeneca Pharmaceuticals Lp 2 $4,777.50

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$6,138
Consulting Fee
$4,778
Food and Beverage
$96
Debt Forgiveness
$3

Frequently asked questions

Auto-generated from federal data
What is Dr. Nikoletta Sidiropoulos's medical specialty?
Dr. Nikoletta Sidiropoulos practices Molecular Genetic Pathology (Medical Genetics) Physician in Burlington, VT.
Where does Dr. Nikoletta Sidiropoulos practice?
Dr. Nikoletta Sidiropoulos practices at 111 Colchester Ave, Burlington, VT 054011473. Office phone: 8023567323.
What is Dr. Nikoletta Sidiropoulos's NPI?
Dr. Nikoletta Sidiropoulos's National Provider Identifier (NPI) is 1356446017, issued by NPPES.

Methodology · sources used on this page

All figures on this page come from publicly available federal datasets. We do not edit, score, or summarise the underlying data. Profile generated Jul 26, 2026.

NPPES Provider identifiers and practice info May 11, 2026
Open Payments Industry payments to providers (Sunshine Act) May 11, 2026
Medicare Procedure Utilization Services and allowed amounts by HCPCS May 11, 2026
Medicare Part D Prescription drug claims May 11, 2026
CMS MIPS Quality performance scores May 11, 2026
OIG LEIE Federal exclusion / sanctions list May 11, 2026

Information based on publicly available federal data. Not medical advice. Report incorrect data ›